γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

被引：22

作者：

Luong-Gardiol, Noemie ^{[1
,8
]}

Siddiqui, Imran ^{[1
]}

Pizzitola, Irene ^{[1
]}

Jeevan-Raj, Beena ^{[1
]}

Charmoy, Melanie ^{[1
]}

Huang, Yun ^{[2
,3
]}

Irmisch, Anja ^{[4
,9
]}

Curtet, Sara ^{[1
]}

Angelov, Georgi S. ^{[1
]}

Danilo, Maxime ^{[1
,10
]}

Juilland, Melanie ^{[5
]}

Bornhauser, Beat ^{[2
,3
]}

Thome, Margot ^{[5
]}

Hantschel, Oliver ^{[4
]}

Chalandon, Yves ^{[6
]}

Cazzaniga, Gianni ^{[7
]}

Bourquin, Jean-Pierre ^{[2
,3
]}

Huelsken, Joerg ^{[4
]}

Held, Werner ^{[1
]}

机构：

[1] Univ Lausanne, Dept Oncol UNIL CHUV, Epalinges, Switzerland

[2] Univ Childrens Hosp Zurich, Dept Pediat Oncol, Zurich, Switzerland

[3] Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland

[4] Fed Univ Technol Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland

[5] Univ Lausanne, Dept Biochem, Epalinges, Switzerland

[6] Hop Univ Geneve, Serv Hematol, Geneva, Switzerland

[7] Pediat Clin Univ Milano Bicocca, Ctr Ric Tettamanti, Monza, Italy

[8] Debiopharm Int SA, Ch Messidor 5-7, CH-1002 Lausanne, Switzerland

[9] Univ Hosp Zurich, Clin Dermatol, Wagistr 14, CH-8952 Schlieren, Switzerland

[10] Phi Pharma SA, Pl Midi 36, CH-1950 Sion, Switzerland

来源：

CANCER CELL | 2019年 / 35卷 / 04期

基金：

瑞士国家科学基金会;

关键词：

CHRONIC MYELOID-LEUKEMIA; BETA-CATENIN; STEM-CELLS; C-MYC; BCR-ABL; TRANSCRIPTIONAL REGULATION; TRANSLOCATION PRODUCTS; SURVIVIN; PATHWAY; KINASE;

D O I：

10.1016/j.ccell.2019.03.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The BCR-ABL1 fusion protein is the cause of chronic myeloid leukemia (CML) and of a significant fraction of adult-onset B cell acute lymphoblastic leukemia (B-ALL) cases. Using mouse models and patient-derived samples, we identified an essential role for gamma-catenin in the initiation and maintenance of BCR-ABL1(+) B-ALL but not CML. The selectivity was explained by a partial gamma-catenin dependence of MYC expression together with the susceptibility of B-ALL, but not CML, to reduced MYC levels. MYC and gamma-catenin enabled B-ALL maintenance by augmenting BIRC5 and enforced BIRC5 expression overcame gamma-catenin loss. Since gamma-catenin was dispensable for normal hematopoiesis, these lineage- and disease-specific features of canonical Wnt signaling identified a potential therapeutic target for the treatment of BCR-ABL1(+) B-ALL.

引用

页码：649 / +

页数：25

共 52 条

[1] Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis [J].

Aceto, Nicola ;

Bardia, Aditya ;

Miyamoto, David T. ;

Donaldson, Maria C. ;

Wittner, Ben S. ;

Spencer, Joel A. ;

Yu, Min ;

Pely, Adam ;

Engstrom, Amanda ;

Zhu, Huili ;

Brannigan, Brian W. ;

Kapur, Ravi ;

Stott, Shannon L. ;

Shioda, Toshi ;

Ramaswamy, Sridhar ;

Ting, David T. ;

Lin, Charles P. ;

Toner, Mehmet ;

Haber, Daniel A. ;

Maheswaran, Shyamala .

CELL, 2014, 158 (05) :1110-1122

[2]

Aktary Zackie, 2012, Int J Cell Biol, V2012, P189521, DOI 10.1155/2012/189521

[3] Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation [J].

Coluccia, Addolorata Maria Luce ;

Vacca, Angelo ;

Dunach, Mireia ;

Mologni, Luca ;

Redaelli, Sara ;

Bustos, Victor H. ;

Benati, Daniela ;

Pinna, Lorenzo A. ;

Gambacorti-Passerini, Carlo .

EMBO JOURNAL, 2007, 26 (05) :1456-1466

[4] Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy [J].

Fang, Zhi Hong ;

Dong, Chun Lan ;

Chen, Zhong ;

Zhou, Bin ;

Liu, Na ;

Lan, Hai Feng ;

Liang, Lu ;

Liao, Wen Bin ;

Zhang, Lei ;

Han, Zhong Chao .

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) :2039-2052

[5] Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells [J].

Feldhahn, Niklas ;

Henke, Nadine ;

Melchior, Kai ;

Duy, Cihangir ;

Soh, Bonaventure Ndikung ;

Klein, Florian ;

von Levetzow, Gregor ;

Giebel, Bernd ;

Li, Aihong ;

Hofmann, Wolf-Karsten ;

Jumaa, Hassan ;

Mueschen, Markus .

JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (05) :1157-1166

[6] Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia [J].

Gang, E. J. ;

Hsieh, Y-T ;

Pham, J. ;

Zhao, Y. ;

Nguyen, C. ;

Huantes, S. ;

Park, E. ;

Naing, K. ;

Klemm, L. ;

Swaminathan, S. ;

Conway, E. M. ;

Pelus, L. M. ;

Crispino, J. ;

Mullighan, C. G. ;

McMillan, M. ;

Mueschen, M. ;

Kahn, M. ;

Kim, Y-M .

ONCOGENE, 2014, 33 (17) :2169-2178

[7] Identification of c-MYC as a target of the APC pathway [J].

He, TC ;

Sparks, AB ;

Rago, C ;

Hermeking, H ;

Zawel, L ;

da Costa, LT ;

Morin, PJ ;

Vogelstein, B ;

Kinzler, KW .

SCIENCE, 1998, 281 (5382) :1509-1512

[8] Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML [J].

Heidel, Florian H. ;

Bullinger, Lars ;

Feng, Zhaohui ;

Wang, Zhu ;

Neff, Tobias A. ;

Stein, Lauren ;

Kalaitzidis, Demetrios ;

Lane, Steve W. ;

Armstrong, Scott A. .

CELL STEM CELL, 2012, 10 (04) :412-424

[9] Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants [J].

Hemann, MT ;

Bric, A ;

Teruya-Feldstein, J ;

Herbst, A ;

Nilsson, JA ;

Cordon-Cardo, C ;

Cleveland, JL ;

Tansey, WP ;

Lowe, SW .

NATURE, 2005, 436 (7052) :807-811

[10] β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia [J].

Hu, Y. ;

Chen, Y. ;

Douglas, L. ;

Li, S. .

LEUKEMIA, 2009, 23 (01) :109-116

← 1 2 3 4 5 6 →